Hemington Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $169K | Sell |
419
-86
| -17% | -$34.7K | 0.02% | 152 |
|
2025
Q1 | $251K | Buy |
505
+43
| +9% | +$21.4K | 0.04% | 112 |
|
2024
Q4 | $240K | Buy |
462
+7
| +2% | +$3.64K | 0.06% | 111 |
|
2024
Q3 | $248K | Buy |
455
+2
| +0.4% | +$1.09K | 0.07% | 105 |
|
2024
Q2 | $250K | Buy |
453
+16
| +4% | +$8.83K | 0.08% | 100 |
|
2024
Q1 | $255K | Buy |
437
+25
| +6% | +$14.6K | 0.09% | 97 |
|
2023
Q4 | $219K | Sell |
412
-30
| -7% | -$15.9K | 0.08% | 98 |
|
2023
Q3 | $223K | Sell |
442
-57
| -11% | -$28.8K | 0.11% | 85 |
|
2023
Q2 | $260K | Sell |
499
-12
| -2% | -$6.25K | 0.11% | 88 |
|
2023
Q1 | $294K | Buy |
511
+4
| +0.8% | +$2.3K | 0.12% | 82 |
|
2022
Q4 | $279K | Buy |
507
+3
| +0.6% | +$1.65K | 0.12% | 80 |
|
2022
Q3 | $256K | Sell |
504
-2
| -0.4% | -$1.02K | 0.11% | 80 |
|
2022
Q2 | $275K | Buy |
506
+19
| +4% | +$10.3K | 0.11% | 84 |
|
2022
Q1 | $288K | Buy |
+487
| New | +$288K | 0.1% | 90 |
|
2021
Q4 | – | Sell |
-363
| Closed | -$207K | – | 99 |
|
2021
Q3 | $207K | Buy |
+363
| New | +$207K | 0.08% | 94 |
|